Inhibition of Pyruvate Kinase M2 by Reactive Oxygen Species Contributes to Cellular Antioxidant Responses
Beth Israel Deaconess Medical Center · Harvard University · +5 more institutions
Abstract
Control of intracellular reactive oxygen species (ROS) concentrations is critical for cancer cell survival. We show that, in human lung cancer cells, acute increases in intracellular concentrations of ROS caused inhibition of the glycolytic enzyme pyruvate kinase M2 (PKM2) through oxidation of Cys(358). This inhibition of PKM2 is required to divert glucose flux into the pentose phosphate pathway and thereby generate sufficient reducing potential for detoxification of ROS. Lung cancer cells in which endogenous PKM2 was replaced with the Cys(358) to Ser(358) oxidation-resistant mutant exhibited increased sensitivity to oxidative stress and impaired tumor formation in a xenograft model. Besides promoting…
Citation impact
- FWCI
- 34.09
- Percentile
- 100%
- References
- 28
Authors
13- DADimitrios AnastasiouCorresponding
Beth Israel Deaconess Medical Center, Harvard University, Center for Systems Biology
- GPGeorge Poulogiannis
Beth Israel Deaconess Medical Center, Harvard University, Center for Systems Biology
- JMJohn M. Asara
Beth Israel Deaconess Medical Center, Harvard University
- MBMatthew B. Boxer
National Institutes of Health, National Human Genome Research Institute
- JJJian‐kang Jiang
National Institutes of Health, National Human Genome Research Institute
Topics & keywords
- Reactive oxygen species
- Antioxidant
- Pyruvate kinase
- Chemistry
- PKM2
- Cell biology
- Oxygen
- Biochemistry